Recently Featured

Baxter Warning Letter Ends a $50M Cephalosporin Line With 60% Margins

November 3, 2026
Baxter International is shutting down a cephalosporin business that, by its own numbers, brings in about $50 million in sales and $30 million in operating income this year. The reason is an FDA warning letter to its Round Lake, Illinois injectables plant, and the bill for that letter lands partly on the hospitals and distributors…
Brain MRI scan showing structural changes

Study Links Pulmonary Hypertension to Cognitive Decline

November 3, 2026
A study by University of Pittsburgh and UPMC researcher-clinicians has uncovered a connection between pulmonary hypertension (PH) and cognitive decline. The research team conducted a multimodal investigation involving brain MRI studies, blood-based molecular profiling, and functional studies in mouse models, linking specific brain abnormalities in PH to inflammatory processes affecting both the lungs and heart.…
Courtroom setting for bankruptcy auction

Karyopharm to Auction Itself Amid Bankruptcy

November 3, 2026
Karyopharm, a company facing significant debt issues, is set to be the lead bidder in a court-supervised auction. This auction comes after Karyopharm recently negotiated a forbearance deal to delay its debt payments. The situation highlights the financial challenges the company is currently navigating. This development could have implications for stakeholders in the pharmaceutical sector,…
Generic HIV prevention injection vial

FDA Approves Generic HIV Prevention Shot by Dr. Reddy’s Laboratories

November 3, 2026
After months of anticipation, the Food and Drug Administration gave tentative approval to Dr. Reddy’s Laboratories to make a generic version of a groundbreaking HIV prevention medicine, a key step in widening access for dozens of low- and middle-income countries. The company plans to start shipping the medicine next month as part of an effort…

Ongoing Cases